HDAC9 and Miyoshi myopathy: Using caspase-3 activity assay to confirm apoptotic responses to the agents and CellTitler-Glo viability testing, the researchers showed that combination therapy with TRAIL and HDAC inhibitors induced apoptosis, and MM cells in 3D spheroid cultures were more sensitive to drug treatment compared to suspension cell culture.